Skip to main content
. 2017 Mar 24;8(44):75874–75880. doi: 10.18632/oncotarget.16548

Figure 2. Efficacy of cyclophosphamide (CPA), temozolomide (TEM) and TEM combined with irinotecan (IRN).

Figure 2

CPA (140 mg/kg, i.p., qw×3); TEM (25 mg/kg, p.o., qd×21); TEM (25 mg/kg, p.o., qd×21) combined with IRN (4 mg/kg, i.p., qd×21). Tumor volume was measured at the indicated time points after the onset of treatment. Please see the Materials and Methods for details. N = 8 mice/group. *P=0.0002; **P<0.0001.